These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24586672)

  • 1. Prevalence of and associated factors for adult attention deficit hyperactivity disorder in young Swiss men.
    Estévez N; Eich-Höchli D; Dey M; Gmel G; Studer J; Mohler-Kuo M
    PLoS One; 2014; 9(2):e89298. PubMed ID: 24586672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult attention-deficit/hyperactivity disorder and its association with substance use and substance use disorders in young men.
    Estévez N; Dey M; Eich-Höchli D; Foster S; Gmel G; Mohler-Kuo M
    Epidemiol Psychiatr Sci; 2016 Jun; 25(3):255-66. PubMed ID: 25989844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is attention deficit/hyperactivity disorder among men associated with initiation or escalation of substance use at 15-month follow-up? A longitudinal study involving young Swiss men.
    Vogel T; Dom G; van de Glind G; Studer J; Gmel G; Strik W; Moggi F
    Addiction; 2016 Oct; 111(10):1867-78. PubMed ID: 27061514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screened Attention Deficit/Hyperactivity Disorder as a Predictor of Substance Use Initiation and Escalation in Early Adulthood and the Role of Self-Reported Conduct Disorder and Sensation Seeking: A 5-Year Longitudinal Study with Young Adult Swiss Men.
    Moggi F; Schorno D; Soravia LM; Mohler-Kuo M; Estévez-Lamorte N; Studer J; Gmel G
    Eur Addict Res; 2020; 26(4-5):233-244. PubMed ID: 32564034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Cross-sectional Cohort Study of Prevalence, Co-Morbidities, and Correlates of Attention-deficit Hyperactivity Disorder among Adult Patients Admitted to the Li Ka Shing Psychiatric Outpatient Clinic, Hong Kong.
    Leung VM; Chan LF
    East Asian Arch Psychiatry; 2017 Jun; 27(2):63-70. PubMed ID: 28652499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attention deficit hyperactivity disorder, other mental health problems, substance use, and driving: examination of a population-based, representative canadian sample.
    Vingilis E; Mann RE; Erickson P; Toplak M; Kolla NJ; Seeley J; Jain U
    Traffic Inj Prev; 2014; 15 Suppl 1():S1-9. PubMed ID: 25307372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and imputed prevalence of ADHD in adult patients with comorbid substance use disorder at a residential treatment facility.
    Adler LA; Guida F; Irons S; Rotrosen J; O'Donnell K
    Postgrad Med; 2009 Sep; 121(5):7-10. PubMed ID: 19820269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttraumatic stress disorder in adult attention-deficit/hyperactivity disorder: clinical features and familial transmission.
    Antshel KM; Kaul P; Biederman J; Spencer TJ; Hier BO; Hendricks K; Faraone SV
    J Clin Psychiatry; 2013 Mar; 74(3):e197-204. PubMed ID: 23561240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention deficit/hyperactivity disorder in female offenders: prevalence, psychiatric comorbidity and psychosocial implications.
    Rösler M; Retz W; Yaqoobi K; Burg E; Retz-Junginger P
    Eur Arch Psychiatry Clin Neurosci; 2009 Mar; 259(2):98-105. PubMed ID: 18806916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult attention deficit hyperactivity disorder symptom profiles and concurrent problems with alcohol and cannabis: sex differences in a representative, population survey.
    Kolla NJ; van der Maas M; Toplak ME; Erickson PG; Mann RE; Seeley J; Vingilis E
    BMC Psychiatry; 2016 Feb; 16():50. PubMed ID: 26920911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An epidemiological study of ADHD, substance use, and comorbid problems in incarcerated women in Sweden.
    Konstenius M; Larsson H; Lundholm L; Philips B; van de Glind G; Jayaram-Lindström N; Franck J
    J Atten Disord; 2015 Jan; 19(1):44-52. PubMed ID: 22797213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers.
    Schubiner H; Tzelepis A; Milberger S; Lockhart N; Kruger M; Kelley BJ; Schoener EP
    J Clin Psychiatry; 2000 Apr; 61(4):244-51. PubMed ID: 10830144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of attention deficit-/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates.
    Rösler M; Retz W; Retz-Junginger P; Hengesch G; Schneider M; Supprian T; Schwitzgebel P; Pinhard K; Dovi-Akue N; Wender P; Thome J
    Eur Arch Psychiatry Clin Neurosci; 2004 Dec; 254(6):365-71. PubMed ID: 15538605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: A population-based cross-sectional study.
    Chen Q; Hartman CA; Haavik J; Harro J; Klungsøyr K; Hegvik TA; Wanders R; Ottosen C; Dalsgaard S; Faraone SV; Larsson H
    PLoS One; 2018; 13(9):e0204516. PubMed ID: 30256837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between attention-deficit hyperactivity disorder symptoms and problem gambling: A mediation analysis of influential factors among 7,403 individuals from the UK.
    Jacob L; Haro JM; Koyanagi A
    J Behav Addict; 2018 Sep; 7(3):781-791. PubMed ID: 30238788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients.
    van de Glind G; van den Brink W; Koeter MW; Carpentier PJ; van Emmerik-van Oortmerssen K; Kaye S; Skutle A; Bu ET; Franck J; Konstenius M; Moggi F; Dom G; Verspreet S; Demetrovics Z; Kapitány-Fövény M; Fatséas M; Auriacombe M; Schillinger A; Seitz A; Johnson B; Faraone SV; Ramos-Quiroga JA; Casas M; Allsop S; Carruthers S; Barta C; Schoevers RA; ; Levin FR
    Drug Alcohol Depend; 2013 Oct; 132(3):587-96. PubMed ID: 23660242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life in substance use disorder patients with and without attention deficit hyperactivity disorder 12 months after treatment: a naturalistic follow-up study.
    Flores-García L; Lensing MB; Ytterstad E; Eisemann M
    Atten Defic Hyperact Disord; 2019 Sep; 11(3):299-310. PubMed ID: 30903585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
    Bernardi S; Faraone SV; Cortese S; Kerridge BT; Pallanti S; Wang S; Blanco C
    Psychol Med; 2012 Apr; 42(4):875-87. PubMed ID: 21846424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention Deficit Hyperactivity Disorder among Clients Diagnosed with a Substance Use Disorder in the Therapeutic Communities: Prevalence and Psychiatric Comorbidity.
    Miovský M; Lukavská K; Rubášová E; Šťastná L; Šefránek M; Gabrhelík R
    Eur Addict Res; 2021; 27(2):87-96. PubMed ID: 32781442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.